If you've ever lost weight only to gain it back, you're not alone — and it's not your fault. The science of obesity has advanced dramatically in recent years, revealing that weight regain after dieting is a biological response, not a failure of willpower.
When you lose weight through calorie restriction alone, your body fights back. Levels of hunger hormones (like ghrelin) increase, while satiety hormones (like leptin) decrease. Your metabolic rate drops. Your brain literally rewires to make food more appealing and satisfying. This phenomenon, known as metabolic adaptation, can persist for years after weight loss.
This is why approximately 80% of people who lose significant weight through dieting alone regain it within five years. The deck is biologically stacked against them.
GLP-1 receptor agonist medications work by addressing these biological mechanisms directly. By mimicking the GLP-1 hormone at therapeutic levels, these medications reduce appetite at the brain level, slow gastric emptying so you feel full longer, improve insulin sensitivity and blood sugar regulation, and reduce food-related reward signaling in the brain.
Unlike restrictive diets, GLP-1 medications work with your biology rather than against it. They essentially recalibrate the set point that your body defends, making it possible to maintain a lower weight without the constant battle against hunger and cravings.
While medication provides the biological foundation, sustainable weight loss also requires attention to nutrition, movement, sleep, and stress management. At Precision Weight + Wellness, we integrate all of these elements into your treatment plan.
Dr. Rhee works with you to develop sustainable eating patterns (not restrictive diets), appropriate physical activity recommendations, sleep optimization strategies, and stress management techniques. The goal is to build habits that support your new weight long-term, so that when it's time to taper or discontinue medication, you have a solid lifestyle foundation in place.
The latest research shows that GLP-1 medications don't just help with weight loss — they may also provide significant cardiovascular protection, reduce inflammation, and improve outcomes for a range of obesity-related conditions.
The SELECT trial demonstrated that Semaglutide reduced the risk of major cardiovascular events (heart attack, stroke, and cardiovascular death) by 20% in people with obesity but without diabetes. This is groundbreaking evidence that treating obesity with medication has benefits far beyond the scale.
If you're tired of the diet cycle and ready for a science-based approach to lasting weight management, Precision Weight + Wellness can help. Schedule a consultation with Dr. Rhee to learn how modern obesity medicine can work for you.